PubMed

FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges.

PMID: 41298848 · 2025-11-26

J, u, l, i, a, n, , H, e, r, p, e, r, t, z, ;, , A, r, i, e, l, , D, , S, t, e, r, n, ;, , N, i, l, s, , O, p, e, l, ;, , U, l, r, i, c, h, , R, e, i, n, i, n, g, h, a, u, s, ;, , J, o, h, n, , T, o, r, o, u, s

학술지Npj mental health research

연도2025-11-26

PMID41298848

초록

FDA approval is widely regarded as a benchmark of quality for medical devices. However, concerns persist regarding its regulatory framework for digital mental health devices. This perspective article examined FDA-authorized Software as a Medical Device (SaMD) in mental health, tracing the devices' regulatory lineage through the De Novo and 510(k)-clearance pathways while assessing the quality of evidence that led to their authorization. Many 510(k)-cleared devices lacked direct evidence of effec

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.